Journal
CARBOHYDRATE POLYMERS
Volume 173, Issue -, Pages 223-232Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.carbpol.2017.06.006
Keywords
Starch coating; Hollow nanocarriers; Gel; Calcium carbonate; Drug encapsulation
Categories
Ask authors/readers for more resources
Hollow nanoparticles (HNPs) have been widely regarded as controlled drug carriers owing to their advantages, such as high drug-loading efficiency and superior control over drug delivery and release. In this study, a facile and efficient strategy has been exploited for preparation of hollow starch nanoparticles (HSNPs) via a sacrificial hard-template process using gelled starch as the shell. These nanocapsules have been characterized through various techniques, including transmission electron microscopy, differential scanning calorimetry, X-ray diffraction, and Fourier transform infrared spectroscopy. The HSNPs have diameters ranging from 30 nm to 300 nm, with shell thickness of 5-10 nm. X-ray diffraction analysis has revealed that HSNPs exhibit B + V type diffraction peaks with a relative crystallinity of 34.2%. Doxorubicin hydrochloride (DOX HCl) was readily encased in the nanocarriers with a high loading efficiency (97.56%) and a high loading content (37.12%). In addition, no cytotoxicity for normal liver cells was found in HSNPs. However, DOX HCl-loaded HSNPs exhibited clear cytotoxicity for liver hepatocellular cells. Thus, the hollow starch nanoparticles form a highly promising platform for cancer therapy. (C) 2017 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available